Skip to main content
. 2022 Sep 14;21(1):71–89. doi: 10.1007/s40258-022-00757-6

Table 1.

Cross-sectional regression of vaccine rollout

Variables (1) (2) (3) (4) (5) (6) (7) (8)
Share of vaccinated population (1 dose) Share of vaccinated population (1 dose) Share of vaccinated population (1 dose) Share of vaccinated population (1 dose) Share of vaccinated population (1 dose) Share of vaccinated population (1 dose) Share of vaccinated population (1 dose) Share of vaccinated population (1 dose)
Potential procurement (Jan 2021) 0.0690*** 0.0480*** 0.0534***
(0.0159) (0.0151) (0.0161)
Domestic production 20.61*** 7.435* 8.897**
(3.075) (3.770) (3.702)
Cumulative cases (end-2020) 5.717*** 5.401*** 4.293*** 4.617***
(0.807) (0.977) (1.047) (1.081)
Health index (WEF) 14.07*** 8.760*** 9.535*** 7.360***
(1.433) (2.347) (2.378) (2.164)
Vaccine acceptance (Jan 2021) 52.45*** 29.80*** 31.98*** 25.99**
(11.86) (11.19) (10.88) (10.74)
Constant 22.55*** 20.23*** 14.15*** − 62.97*** − 11.35 − 64.32*** − 68.67*** − 54.17***
(1.703) (1.795) (1.777) (8.453) (8.003) (14.29) (13.92) (13.05)
Observations 202 202 196 133 95 85 85 85
R-squared 0.042 0.122 0.251 0.355 0.135 0.570 0.549 0.602

Table reports results for Eq. (1). The dependent variable is the share of population that is vaccinated with at least one dose. Robust standard errors

***, **, and * represent statistical significance at 1%, 5%, and 10%, respectively